atai Life Sciences (ATAI) Misses Q4 EPS by 9c

atai Life Sciences (NASDAQ: ATAI) reported Q4 EPS of ($0.24), $0.09 worse than the analyst estimate of ($0.15).

For earnings history and earnings-related data on atai Life Sciences (ATAI) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• BlackBerry (BB) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Uxin Limited (UXIN) Reports Q3 EPS of $0.00